Maraviroc for long COVID. This article goes into l
Post# of 145337
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Quote:
In a feasibility study, Putrino's lab will study two repurposed HIV antivirals, emtricitabine/tenofovir (Truvada) and maraviroc. "Maraviroc has had some early published evidence that it does have some antiviral action on SARS-CoV-2 in the body," he noted. "Truvada also has some weaker evidence showing it has action on SARS-CoV-2, but more importantly, it has strong evidence that it can act quite aggressively on persistent EBV," which may be a factor in a subset of long COVIDopens in a new tab or window patients.
https://www.medpagetoday.com/neurology/longco...ate_active
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)